Benzinga | Feb 16, 2021 09:38AM EST

PAVmed Announces First US Patient Has Undergone Carpal Tunnel Release Using CarpX Device

NEW YORK, Feb. 16, 2021 (GLOBE NEWSWIRE) -- PAVmed Inc. (NASDAQ:PAVM, PAVMZ))))) (the "Company" or "PAVmed"), a highly differentiated, multi-product, commercial-stage medical technology company, today announced that the first U.S. patient recently underwent successful carpal tunnel release using its CarpX(r) minimally invasive carpal tunnel device.